The biopartnering and investment conference BioTrinity in London will explore the healthcare solutions of tomorrow.
Panel discussions at the event include AI and Drug discovery, An insight into Nanotechnology, Next generation chemistry and Fintech and the future of the investment industry.
The first day of the event will also include panel discussions on AIM v Nasdaq v European listing – what’s best for you? and the future of medical 3D printing. There will also be roundtable discussions on alternative sources of funding.
The second day highlights, for example, include a case study on collaborating with big pharma and panel discussions on the potential of precision medicine and cell and gene therapy: cost v rarity, as well as a round table discussion on the pros and cons of IPO.
Read more about BioTrinity here!